APPARENTLY the rather elaborate Jakarta Stock Exchange (JSE) building has been hiding a really chronic ulcer. The case began six years ago and there are no signs yet of it ending. And like the Manulife case, there is even the possibility that it could put the international spotlight on Indonesia again.

The JSE lawsuit began when the owner, PT Danareksa Jakarta International, wanted to expand the building. The majority of the shares in Dana